Jennifer Michaelson
Chief Tech/Sci/R&D Officer at CULLINAN THERAPEUTICS, INC.
Net worth: 2 M $ as of 2024-03-30
Profile
Jennifer Michaelson is currently the Chief Scientific Officer at Cullinan Oncology, Inc. She previously worked as the Director-Tumor Immunology at Jounce Therapeutics, Inc. and as the Chief Development Officer-Biologics at Cullinan Oncology LLC from 2020 to 2022.
Additionally, she served as the Head-Biologics at Celsius Therapeutics, Inc. in 2017.
Dr. Michaelson completed her undergraduate degree at Princeton University and obtained a doctorate from Albert Einstein College of Medicine, Inc.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
2024-02-21 | 137,582 ( 0.32% ) | 2 M $ | 2024-03-30 |
Jennifer Michaelson active positions
Companies | Position | Start |
---|---|---|
CULLINAN THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2023-05-31 |
Former positions of Jennifer Michaelson
Companies | Position | End |
---|---|---|
Celsius Therapeutics, Inc.
Celsius Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Celsius Therapeutics, Inc. translates single-cell genomic insights into precision therapeutics for autoimmune diseases and cancer. The company was founded by Jeffrey A. Bluestone, Vijay K. Kuchroo, Christoph S. Lengauer, Aviv Regev and Ramnik Xavier in 2018 and is headquartered in Boston, MA. | Corporate Officer/Principal | 2017-11-30 |
JOUNCE THERAPEUTICS, INC. | Corporate Officer/Principal | 2017-06-30 |
Cullinan Oncology LLC
Cullinan Oncology LLC Financial ConglomeratesFinance Cullinan Oncology LLC is a biopharmaceutical company, which engages in the development of a pipeline of targeted oncology and immuno-oncology therapies for cancer diseases. The company was founded by Patrick Baeuerle on September 15, 2016 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Training of Jennifer Michaelson
Princeton University | Undergraduate Degree |
Albert Einstein College of Medicine, Inc. | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
CULLINAN THERAPEUTICS, INC. | Health Technology |
Private companies | 3 |
---|---|
Jounce Therapeutics, Inc.
Jounce Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Jounce Therapeutics, Inc. is a clinical stage immunotherapy company, which engages in developing treatments for cancer. It also provides novel cancer immunotherapies to attack tumors. The company was founded by Louis M. Weiner, Drew M. Pardoll, Thomas F. Gajewski, James P. Allison, Robert Schreiber, and Padmanee Sharma in 2013 and is headquartered in Cambridge, MA. | Commercial Services |
Cullinan Oncology LLC
Cullinan Oncology LLC Financial ConglomeratesFinance Cullinan Oncology LLC is a biopharmaceutical company, which engages in the development of a pipeline of targeted oncology and immuno-oncology therapies for cancer diseases. The company was founded by Patrick Baeuerle on September 15, 2016 and is headquartered in Cambridge, MA. | Finance |
Celsius Therapeutics, Inc.
Celsius Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Celsius Therapeutics, Inc. translates single-cell genomic insights into precision therapeutics for autoimmune diseases and cancer. The company was founded by Jeffrey A. Bluestone, Vijay K. Kuchroo, Christoph S. Lengauer, Aviv Regev and Ramnik Xavier in 2018 and is headquartered in Boston, MA. | Health Technology |
- Stock Market
- Insiders
- Jennifer Michaelson